Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
Atezolizumab
Hoffmann-La Roche
Carcinoma, Non-Small-Cell Lung
1 trial -
Babaodan oral capsule
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Bavencio 20 mg/mL concentrate for solution for infusion
Disc Medicine
urothelial cancer, Bladder cancer, muscle invasive bladder cancer
1 trial -
Blinatumomab
The First People's Hospital of Lianyungang
Acute B-cell Lymphoblastic Leukemia
1 trial -
Brentuximab vedotin
Takeda
Lymphoma
2 trials -
Brentuximab vedotin
Takeda
T-Cell Lymphoma
1 trial -
Brucea javanica oil emulsion injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
C4221026
Pfizer Australia Pty Ltd
Solid tumors
1 trial -
CDRB436G2401
Novartis Pharmaceuticals
Children and Adolescents with Cancers Harboring V600 mutation.
1 trial -
CERITINIB
Novartis Pharmaceuticals
non small cell lung cancer
1 trial -
CLEAN+
The George Institute
colorectal cancer early detection
1 trial -
CLEE011A2412B
Novartis Pharmaceuticals
HR+, HER2- advanced or metastatic breast cancer
1 trial -
CML1415 - Sustrenim
Fondazione Telethon ETS
Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
1 trial -
CO2MO
Disc Medicine
Melanoma
1 trial -
COBICISTAT , OLAPARIB
Disc Medicine
Cancer
1 trial -
Camrelizumab + chemotherapy+Thalidomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Chemoembolization and Response-Dependent Resection
The First People's Hospital of Lianyungang
Resectable Hepatocellular Carcinoma Beyond Milan Criteria
1 trial -
Chlorhexidine gluconate
Hospital Authority, Hong Kong
Liver Tumors
1 trial -
Cinobufacini injection
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie
Disc Medicine
Locally advanced head and neck squamous cell carcinoma
1 trial -
Cytokine-induced killer cells+ FOLFOX4
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
D9311L00001
AstraZeneca
Advanced or recurrent endometrial cancer
1 trial -
DOTAREM for Breast Cancer
Disc Medicine
Breast Cancer
1 trial -
DS-8201a
AstraZeneca AB
Treatment of patients with HER2-positive breast cancer with or without brain metastasis
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
Dexamethasone tablets for Solid tumors
Disc Medicine
Solid tumors
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dexmedetomidine
Peking University Third Hospital
Breast Cancer
1 trial -
Dexmedetomidine Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dotarem®
Guerbet
Primary Brain Tumor
1 trial -
Durvalumab
AstraZeneca
Solid Tumor
1 trial -
EC-120888
CERO THERAPEUTICS HOLDINGS, INC.
Completely resected stage I or IIA non-squamous non-small cell lung cancer (NSCLC)
1 trial -
EC/2013/472
Takeda
Prostate or Bladder Cancer
1 trial -
Enhanced dermatologic management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC (Advanced Non-small Cell Lung Cancer)
1 trial -
Epirubicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Hepatocellular
1 trial -
Etoposide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mantle Cell Lymphoma
1 trial -
Fentanyl Buccal Tablet (FBT)
Teva Pharma GmbH
Cancer Pain
1 trial -
Fruquintinib
Takeda
Colorectal Cancer
1 trial -
GAVRETO ®(pralsetinib) capsules
RIGEL PHARMACEUTICALS INC
Patients with advanced or metastatic solid tumors
1 trial -
GEICAM/2023-09
Ningbo Cancer Hospital
Early Breast Cancer
1 trial -
Gadoterate meglumine
Guerbet
Hepatocellular Carcinoma
1 trial -
INDOCYANINE GREEN
Disc Medicine
cervical cancer stage I-IIA
1 trial -
INDOCYANINE GREEN
The George Institute
Patients with liver tumors that will undergo minimally invasive liver surgery
1 trial -
ITALIC-RCC
Fondazione Telethon ETS
metastatic or locally advanced renal cell carcinoma
1 trial -
Ibrutinib
AbbVie Deutschland GmbH & Co. KG
1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 3. Waldenstrom macroglobulinemia 4. Multiple Myeloma 5. Marginal Zone Lymphoma 6. Diffuse Large B-Cell Lymphoma 7. Urothelial Carcinoma 8. Breast Cancer 9. Acute Myeloid Leukemia 10. Graft vs Host Disease 11. Mantle Cell Lymphoma
1 trial -
Ilaprazole
Yang Xiaotian
Gastric Cancer
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.